- Filed
- May 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 21, 2025 | 21.55M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $5.87M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $5.38M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $5.87M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $5.38M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $151.75K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $143.35K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $169.48K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $161.08K |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 4.11M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 3.6M sh |
| Operating Cash Flow restated | Q2 2025 · Mar 31, 2024 | −$371.66K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$5.18M |
| Stockholders Equity restated | Q2 2025 · Sep 30, 2023 | −$5.1M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.03 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.07 |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $40.13K |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $87.66K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | −$122.45K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | −$267.39K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$101.07K |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$223.85K |
| Revenue | Q2 2025 · Mar 31, 2024 | $59.06K |
| Revenue | Q2 2025 · Mar 31, 2024 | $118.13K |